Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012346 |
---|---|
Receipt number | R000014435 |
Scientific Title | Minodronate for glucocorticoid induced osteoporosis versus alfacalcidol |
Date of disclosure of the study information | 2013/11/19 |
Last modified on | 2021/12/13 13:20:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/11/19 16:45:55 | ||
2 | Update | 2013/11/22 17:00:32 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address |
|
3 | Update | 2014/02/12 09:40:50 | Recruitment status |
|
4 | Update | 2014/07/15 08:33:42 | Last name of contact person Last name of contact person Address Address TEL |
|
5 | Update | 2015/01/20 11:52:21 | Organization Organization Division name Division name Division name Division name Name of person sending information Name of person sending information Division name Division name |
|
6 | Update | 2015/07/03 19:57:51 | Last name of contact person Last name of contact person Division name Division name |
|
7 | Update | 2016/06/20 10:14:29 | Recruitment status |
|
8 | Update | 2017/12/22 10:52:16 | Last name of contact person Last name of contact person Division name Address Address TEL Name of person sending information Division name Address Address TEL Name of primary person or sponsor Organization |
|
9 | Update | 2018/09/05 14:00:16 | Recruitment status |
|
10 | Update | 2018/10/19 13:58:24 | Recruitment status |
|
11 | Update | 2018/10/19 14:05:14 | Last name of contact person Last name of contact person Address Address TEL Address Address TEL |
|
12 | Update | 2019/03/01 12:06:35 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
13 | Update | 2021/12/13 12:53:25 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
14 | Update | 2021/12/13 13:04:19 | Date of IRB |
|
15 | Update | 2021/12/13 13:20:27 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |